ELSE-KROENER STRASSE 1, BAD HOMBURG, 2M
Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
Material disclosure
Cassie McLean Appointed As New Management Board Member For Care Delivery
Reports Operating Income Excluding Special Items To Be Above Market Expectations In The Second Quarter Of 2026 And Confirms Its Outlook For The Financial Year 2026
Complete Overview Of The Second Quarter And First Half Year 2026
Launches First Tranche of Its Share Buyback Program of Up to EUR 600 Million
Announces New Share Buyback Program With A Total Volume Of Around EUR 1 Billion With Phased Execution Over 12 Months
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus Filed Pursuant to Rule 425
Amended Registration Statement for Securities Issued in Business-Combination Transactions
Registration Statement for Securities Issued in Business-Combination Transactions
No filings found
Amended Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
Annual Report of Employee Stock Purchase
Initial Statement of Beneficial Ownership
Specialized Disclosure Report
Iran Notice